Furthermore, blocking RANK in both human CLL and the TCL1-driven CLL mouse model reduces disease progression in preclinical models, confirming the relevance of RANK signaling for CLL progression [9]. This evidence concerns the gene TNFRSF11A and B-cell chronic lymphocytic leukemia.